211 – 220 of 1033
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=""
width=""
height=""
allowtransparency="true"
frameborder="0">
</iframe>
- 2016
-
Mark
Drug use and healthcare consumption among persons with intellectual disabilities and dementia: A registry study
(2016) 2016 IASSIDD World Congress In Journal of Intellectual Disability Research 60(7-8). p.632-632
- Contribution to journal › Published meeting abstract
-
Mark
Aging with intellectual disability: A prevalence study of older people in Sweden
- Contribution to journal › Published meeting abstract
-
Mark
Patterns of somatic healthcare utilisation in people with intellectual disabilities: A Swedish 11-year register-based study
(2016) 2016 IASSIDD World Congress In Journal of Intellectual Disability Research 60(7-8). p.731-731
- Contribution to journal › Published meeting abstract
-
Mark
Development after pediatric brain tumor-a longitudinal study
- Contribution to journal › Article
-
Mark
Immunohistochemical localization of the calcitonin gene-related peptide binding site in the primate trigeminovascular system using functional antagonist antibodies
- Contribution to journal › Article
-
Mark
Heterozygous PINK1 p.G411S mutation increases risk for Parkinson's disease (PD)
(2016) 20th International Congress of Parkinson's Disease and Movement Disorders In Movement Disorders 31(Suppl. S2). p.282-282
- Contribution to journal › Published meeting abstract
-
Mark
Elevated CA125 is associated with incident heart failure and increased mortality in patients with acute coronary syndrome
- Contribution to journal › Published meeting abstract
-
Mark
Identification of additional risk loci for stroke and small vessel disease: a meta-analysis of genome-wide association studies
- Contribution to journal › Article
-
Mark
Loci associated with ischaemic stroke and its subtypes (SiGN): A genome-wide association study
- Contribution to journal › Article
-
Mark
Antiretroviral resistance at virological failure in the NEAT 001/ANRS 143 trial: Raltegravir plus darunavir/ritonavir or tenofovir/emtricitabine plus darunavir/ritonavir as first-line ART
- Contribution to journal › Article
